search
Back to results

Efficacy of EndoClot™ Spraying After Endoscopic Resection of Large Colorectal Polyps (EndoClot™)

Primary Purpose

Wound Endoscopical, Colon, After Polyp Resection, Colon

Status
Terminated
Phase
Not Applicable
Locations
Germany
Study Type
Interventional
Intervention
use of EndoClot
Sponsored by
Universitätsklinikum Hamburg-Eppendorf
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Wound Endoscopical, Colon focused on measuring colon endoscopic mucosa resection (EMR), delayed bleeding, colonoscopy, polyp resection

Eligibility Criteria

18 Years - 89 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Patients with a ≥20mm colon non-pedunculated polyp who are undergoing an ESD or EMR resection
  • signed Informed Consent

Exclusion Criteria:

  • Patients with known (biopsy proven) or strongly suspected invasive carcinoma in a potential study polyp
  • Pedunculated polyps (as defined by Paris Classification type Ip or Isp)
  • ulcerated depressed lesions (as defined by Paris Classification type III)
  • polyposis syndromes
  • inflammatory bowel disease
  • emergency colonoscopy
  • Poor general health (ASA (American Society of Anaesthesiologists) class>3)
  • Patients with coagulopathy with an elevated International Normalized Ratio (INR )≥1.5, or platelets <50
  • Poor bowel preparation
  • pregnancy or breastfeeding
  • Intervention planned using ORISE™ (Boston Medical) or LIFTUP™ (Ovesco) as lifting agents

Sites / Locations

  • Vivantes Auguste-Viktoria-Klinikum
  • University Hospital Hamburg Eppendorf
  • Evangelisches Amalie Sieveking Krankenhaus
  • UKGM Marburg, Klinik für Gastroenterologie
  • Klinikum Südstadt Rostock

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Sham Comparator

Arm Label

EndoClot group

Control group

Arm Description

patients who are being provided with EndoClot adhesive spray after polyp resection

no further prophylactic bleeding prevention after polyp resection

Outcomes

Primary Outcome Measures

delayed bleeding complication: hospitalization
hospitalization after subsequent return to unit / health care facility for evaluation of rectal bleeding
delayed bleeding complication: transfusion
a patient who subsequently had to return to the unit and/or any health care facility for evaluation of rectal bleeding AND who required transfusion
delayed bleeding complication: repeat endoscopy
a patient who subsequently had to return to the unit and/or any health care facility for evaluation of rectal bleeding AND who required a repeat colonoscopy or sigmoidoscopy for examination of the polypectomy site or control of bleeding
delayed bleeding complication:
a patient who subsequently had to return to the unit and/or any health care facility for evaluation of rectal bleeding AND who required surgery

Secondary Outcome Measures

Technical handling
product deployment assumed quantity of entire vial: < 50%/50-70%/100%
Overall complications
an aggregate of all complications that occur at the time of the procedure or during follow-up
Factors associated with complications: polyp size
Factors that may be associated with complications, esp. bleeding
Factors associated with complications: polyp location
Factors that may be associated with complications, esp. bleeding: location of the polyp in the colon (right, left, rectum)
Factors associated with complications: polyp histology
Factors that may be associated with complications, esp. bleeding
Factors associated with complications: polyp morphology
Factors that may be associated with complications, esp. bleeding
Factors associated with complications: polyp resection time
Factors that may be associated with complications, esp. bleeding

Full Information

First Posted
August 29, 2021
Last Updated
July 1, 2023
Sponsor
Universitätsklinikum Hamburg-Eppendorf
search

1. Study Identification

Unique Protocol Identification Number
NCT05029934
Brief Title
Efficacy of EndoClot™ Spraying After Endoscopic Resection of Large Colorectal Polyps
Acronym
EndoClot™
Official Title
Efficacy of EndoClot™ Spraying After Endoscopic Resection of Large Colorectal Polyps: A Randomized Trial.
Study Type
Interventional

2. Study Status

Record Verification Date
July 2023
Overall Recruitment Status
Terminated
Why Stopped
insufficient recruitment of study patients
Study Start Date
August 18, 2021 (Actual)
Primary Completion Date
January 27, 2023 (Actual)
Study Completion Date
January 27, 2023 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Universitätsklinikum Hamburg-Eppendorf

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The effectiveness of colonoscopy in reducing colorectal cancer mortality relies on the detection and removal of neoplastic polyps. Effective and safe resection of larger polyps is particularly important due to their higher potential of malignancy. Large polyps ≥20mm are removed by so-called endoscopic mucosal resection (EMR) (and occasionally endoscopic submucosal dissection (ESD)) using electrocautery snares. Resection of these large polyps is associated with a risk of severe complications that may require hospitalization and additional interventions. The most common risk is delayed bleeding which is observed in approximately 2-10% of patients. In a recent randomized trial, clipping has been shown to reduce bleeding esp. on the right colonic side. However, clipping of larger areas is time consuming and may add to costs in several ways. Our primary aim is to examine whether EndoClot™ application (a special form of longer lasting spray on the mucosal defect after EMR/ESD of large non-pedunculated colorectal polyps (≥20mm) will reduce the risk of delayed bleeding. We hypothesize that EndoClot™ application will reduce the risk of delayed bleeding by at least 3/4 (i.e. from 7.5% to 1.5%) based on an initial assumption of a 7.5% delayed bleeding rate.
Detailed Description
Colorectal cancer is the second most common cause of cancer death in the United States and Europe. The effectiveness of colonoscopy in reducing the risk of dying from colorectal cancer relies on the detection and safe resection of neoplastic polyps to prevent incident cancers. Most polyps are small and can be easily removed using snare with or without electrocautery. Because the risk of prevalent cancer or transition to cancer increases with polyp size, effective and safe resection of large polyps is particularly important. Endoscopic mucosal resection (EMR) is evolving as the primary endoscopic technique to remove large non-pedunculated polyps. These flat or sessile polyps are defined as lateral spreading tumors with a low vertical axis that extend laterally along the luminal wall. Several mostly retrospective studies from Europe, the U.S. and Japan, have demonstrated a high "cure" rate, with results lending credence to the shift from surgical resection to endoscopic management of these lesions. Of concern, however, is 1) a fairly high overall complication rate of 8-26% in prospective studies3-7, and 2) as well the persistence of residual neoplasia on follow-up endoscopy ranging from 16% to 46%3, 6, 8. The former is the main topic of the present study. Severe complications including bleeding associated with a standard diagnostic or screening colonoscopy, which may include resection of predominantly smaller polyps, are uncommon. Significant bleeding occurs in 0.2 to 0.5% of patients (defined as a 2mg drop in Hemoglobin) 9, 10. The risk of severe complications increases with polyp size; here, again, the most common complication is bleeding reported in 2 to 24% of polyp resections. In one recent analysis the rate of delayed bleeding in colonic EMR was 7.5%1. In addition to size, other factors may affect complications. These include type of resection (piecemeal versus en-bloc), polyp location (right colon with a thinner wall than the left colon), age and comorbidities, especially those that affect clotting abilities (e.g. renal insufficiency, liver disease, use of anticoagulation). Studies that have examined variables, which may directly decrease the risk of complications associated with large polyp resection, are limited. It is apparent that resection of a large polyp leaves behind a large mucosal defect. The mucosal ulcer that forms after polyp resection can take several weeks to heal. Bleeding complications typically occur within 7 to 10 days, requiring often admission, a repeat colonoscopy to stop bleeding, and possible blood transfusions. The rates depend on size, and have been shown to be around 1.5%-2.6% overall. It is significantly higher in larger adenomas of 2 cm and more, namely 6.5% in another recent meta analysis. To reduce the risk of bleeding various measures have been proposed which also have been summarized in several recent meta analyses. These include coagulation, clipping and others, but only few randomized trials are available: Coagulation not effective in a recent meta analysis14, but only 4 of the 12 studies were randomized and these included all mostly smaller polyps or polyps of all sizes or pedunculated polyps. In a recent randomized trial, clipping has been shown to reduce bleeding esp. on the right colonic side. However, clipping of larger areas is time consuming and may add to costs in several ways. Our primary aim is to examine whether EndoClot™ application (a special form of longer lasting spray on the mucosal defect after EMR/ESD of large non-pedunculated colorectal polyps (≥20mm) will reduce the risk of delayed bleeding. We hypothesize that EndoClot™ application will reduce the risk of delayed bleeding by at least 3/4 (i.e. from 7.5% to 1.5%) based on an initial assumption of a 7.5% delayed bleeding rate.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Wound Endoscopical, Colon, After Polyp Resection, Colon
Keywords
colon endoscopic mucosa resection (EMR), delayed bleeding, colonoscopy, polyp resection

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
use of EndoClot adhesive after resection vs no use of any preventive action against delayed bleeding (control group)
Masking
Participant
Masking Description
Patients will not be informed about the use of EndoClot adhesive
Allocation
Randomized
Enrollment
96 (Actual)

8. Arms, Groups, and Interventions

Arm Title
EndoClot group
Arm Type
Active Comparator
Arm Description
patients who are being provided with EndoClot adhesive spray after polyp resection
Arm Title
Control group
Arm Type
Sham Comparator
Arm Description
no further prophylactic bleeding prevention after polyp resection
Intervention Type
Procedure
Intervention Name(s)
use of EndoClot
Intervention Description
deployment of EndoClot adhesive spray
Primary Outcome Measure Information:
Title
delayed bleeding complication: hospitalization
Description
hospitalization after subsequent return to unit / health care facility for evaluation of rectal bleeding
Time Frame
30 days
Title
delayed bleeding complication: transfusion
Description
a patient who subsequently had to return to the unit and/or any health care facility for evaluation of rectal bleeding AND who required transfusion
Time Frame
30 days
Title
delayed bleeding complication: repeat endoscopy
Description
a patient who subsequently had to return to the unit and/or any health care facility for evaluation of rectal bleeding AND who required a repeat colonoscopy or sigmoidoscopy for examination of the polypectomy site or control of bleeding
Time Frame
30 days
Title
delayed bleeding complication:
Description
a patient who subsequently had to return to the unit and/or any health care facility for evaluation of rectal bleeding AND who required surgery
Time Frame
30 days
Secondary Outcome Measure Information:
Title
Technical handling
Description
product deployment assumed quantity of entire vial: < 50%/50-70%/100%
Time Frame
20 minutes (assumed deployment time)
Title
Overall complications
Description
an aggregate of all complications that occur at the time of the procedure or during follow-up
Time Frame
procedure to day 30
Title
Factors associated with complications: polyp size
Description
Factors that may be associated with complications, esp. bleeding
Time Frame
30 days
Title
Factors associated with complications: polyp location
Description
Factors that may be associated with complications, esp. bleeding: location of the polyp in the colon (right, left, rectum)
Time Frame
30 days
Title
Factors associated with complications: polyp histology
Description
Factors that may be associated with complications, esp. bleeding
Time Frame
30 days
Title
Factors associated with complications: polyp morphology
Description
Factors that may be associated with complications, esp. bleeding
Time Frame
30 days
Title
Factors associated with complications: polyp resection time
Description
Factors that may be associated with complications, esp. bleeding
Time Frame
30 days

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
89 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patients with a ≥20mm colon non-pedunculated polyp who are undergoing an ESD or EMR resection signed Informed Consent Exclusion Criteria: Patients with known (biopsy proven) or strongly suspected invasive carcinoma in a potential study polyp Pedunculated polyps (as defined by Paris Classification type Ip or Isp) ulcerated depressed lesions (as defined by Paris Classification type III) polyposis syndromes inflammatory bowel disease emergency colonoscopy Poor general health (ASA (American Society of Anaesthesiologists) class>3) Patients with coagulopathy with an elevated International Normalized Ratio (INR )≥1.5, or platelets <50 Poor bowel preparation pregnancy or breastfeeding Intervention planned using ORISE™ (Boston Medical) or LIFTUP™ (Ovesco) as lifting agents
Facility Information:
Facility Name
Vivantes Auguste-Viktoria-Klinikum
City
Berlin
ZIP/Postal Code
12099
Country
Germany
Facility Name
University Hospital Hamburg Eppendorf
City
Hamburg
ZIP/Postal Code
20246
Country
Germany
Facility Name
Evangelisches Amalie Sieveking Krankenhaus
City
Hamburg
ZIP/Postal Code
22359
Country
Germany
Facility Name
UKGM Marburg, Klinik für Gastroenterologie
City
Marburg
ZIP/Postal Code
35043
Country
Germany
Facility Name
Klinikum Südstadt Rostock
City
Rostock
ZIP/Postal Code
18059
Country
Germany

12. IPD Sharing Statement

Citations:
PubMed Identifier
30885778
Citation
Pohl H, Grimm IS, Moyer MT, Hasan MK, Pleskow D, Elmunzer BJ, Khashab MA, Sanaei O, Al-Kawas FH, Gordon SR, Mathew A, Levenick JM, Aslanian HR, Antaki F, von Renteln D, Crockett SD, Rastogi A, Gill JA, Law RJ, Elias PA, Pellise M, Wallace MB, Mackenzie TA, Rex DK. Clip Closure Prevents Bleeding After Endoscopic Resection of Large Colon Polyps in a Randomized Trial. Gastroenterology. 2019 Oct;157(4):977-984.e3. doi: 10.1053/j.gastro.2019.03.019. Epub 2019 Mar 15.
Results Reference
background
PubMed Identifier
19474385
Citation
Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin. 2009 Jul-Aug;59(4):225-49. doi: 10.3322/caac.20006. Epub 2009 May 27.
Results Reference
background
PubMed Identifier
11868011
Citation
Brooker JC, Saunders BP, Shah SG, Thapar CJ, Suzuki N, Williams CB. Treatment with argon plasma coagulation reduces recurrence after piecemeal resection of large sessile colonic polyps: a randomized trial and recommendations. Gastrointest Endosc. 2002 Mar;55(3):371-5. doi: 10.1067/mge.2002.121597.
Results Reference
background
PubMed Identifier
15278051
Citation
Conio M, Repici A, Demarquay JF, Blanchi S, Dumas R, Filiberti R. EMR of large sessile colorectal polyps. Gastrointest Endosc. 2004 Aug;60(2):234-41. doi: 10.1016/s0016-5107(04)01567-6.
Results Reference
background
PubMed Identifier
20588036
Citation
Ferrara F, Luigiano C, Ghersi S, Fabbri C, Bassi M, Landi P, Polifemo AM, Billi P, Cennamo V, Consolo P, Alibrandi A, D'Imperio N. Efficacy, safety and outcomes of 'inject and cut' endoscopic mucosal resection for large sessile and flat colorectal polyps. Digestion. 2010;82(4):213-20. doi: 10.1159/000284397. Epub 2010 Jun 24.
Results Reference
background
PubMed Identifier
21392504
Citation
Moss A, Bourke MJ, Williams SJ, Hourigan LF, Brown G, Tam W, Singh R, Zanati S, Chen RY, Byth K. Endoscopic mucosal resection outcomes and prediction of submucosal cancer from advanced colonic mucosal neoplasia. Gastroenterology. 2011 Jun;140(7):1909-18. doi: 10.1053/j.gastro.2011.02.062. Epub 2011 Mar 8.
Results Reference
background
PubMed Identifier
19748615
Citation
Swan MP, Bourke MJ, Alexander S, Moss A, Williams SJ. Large refractory colonic polyps: is it time to change our practice? A prospective study of the clinical and economic impact of a tertiary referral colonic mucosal resection and polypectomy service (with videos). Gastrointest Endosc. 2009 Dec;70(6):1128-36. doi: 10.1016/j.gie.2009.05.039. Epub 2009 Sep 12.
Results Reference
background
PubMed Identifier
17558911
Citation
Arebi N, Swain D, Suzuki N, Fraser C, Price A, Saunders BP. Endoscopic mucosal resection of 161 cases of large sessile or flat colorectal polyps. Scand J Gastroenterol. 2007 Jul;42(7):859-66. doi: 10.1080/00365520601137280.
Results Reference
background
PubMed Identifier
17179057
Citation
Levin TR, Zhao W, Conell C, Seeff LC, Manninen DL, Shapiro JA, Schulman J. Complications of colonoscopy in an integrated health care delivery system. Ann Intern Med. 2006 Dec 19;145(12):880-6. doi: 10.7326/0003-4819-145-12-200612190-00004.
Results Reference
background
PubMed Identifier
19850154
Citation
Ko CW, Riffle S, Michaels L, Morris C, Holub J, Shapiro JA, Ciol MA, Kimmey MB, Seeff LC, Lieberman D. Serious complications within 30 days of screening and surveillance colonoscopy are uncommon. Clin Gastroenterol Hepatol. 2010 Feb;8(2):166-73. doi: 10.1016/j.cgh.2009.10.007. Epub 2009 Oct 20. Erratum In: Clin Gastroenterol Hepatol. 2010 Dec;8(12):1100.
Results Reference
background
PubMed Identifier
27296945
Citation
Reumkens A, Rondagh EJ, Bakker CM, Winkens B, Masclee AA, Sanduleanu S. Post-Colonoscopy Complications: A Systematic Review, Time Trends, and Meta-Analysis of Population-Based Studies. Am J Gastroenterol. 2016 Aug;111(8):1092-101. doi: 10.1038/ajg.2016.234. Epub 2016 Jun 14.
Results Reference
background
PubMed Identifier
28779355
Citation
Jaruvongvanich V, Prasitlumkum N, Assavapongpaiboon B, Suchartlikitwong S, Sanguankeo A, Upala S. Risk factors for delayed colonic post-polypectomy bleeding: a systematic review and meta-analysis. Int J Colorectal Dis. 2017 Oct;32(10):1399-1406. doi: 10.1007/s00384-017-2870-0. Epub 2017 Aug 5.
Results Reference
background
PubMed Identifier
25681402
Citation
Hassan C, Repici A, Sharma P, Correale L, Zullo A, Bretthauer M, Senore C, Spada C, Bellisario C, Bhandari P, Rex DK. Efficacy and safety of endoscopic resection of large colorectal polyps: a systematic review and meta-analysis. Gut. 2016 May;65(5):806-20. doi: 10.1136/gutjnl-2014-308481. Epub 2015 Feb 13.
Results Reference
background
PubMed Identifier
27708518
Citation
Boumitri C, Mir FA, Ashraf I, Matteson-Kome ML, Nguyen DL, Puli SR, Bechtold ML. Prophylactic clipping and post-polypectomy bleeding: a meta-analysis and systematic review. Ann Gastroenterol. 2016 Oct-Dec;29(4):502-508. doi: 10.20524/aog.2016.0075. Epub 2016 Jul 28.
Results Reference
background
PubMed Identifier
19889407
Citation
ASGE Standards of Practice Committee; Anderson MA, Ben-Menachem T, Gan SI, Appalaneni V, Banerjee S, Cash BD, Fisher L, Harrison ME, Fanelli RD, Fukami N, Ikenberry SO, Jain R, Khan K, Krinsky ML, Lichtenstein DR, Maple JT, Shen B, Strohmeyer L, Baron T, Dominitz JA. Management of antithrombotic agents for endoscopic procedures. Gastrointest Endosc. 2009 Dec;70(6):1060-70. doi: 10.1016/j.gie.2009.09.040. Epub 2009 Nov 3. No abstract available.
Results Reference
background
PubMed Identifier
2032596
Citation
Karita M, Tada M, Okita K, Kodama T. Endoscopic therapy for early colon cancer: the strip biopsy resection technique. Gastrointest Endosc. 1991 Mar-Apr;37(2):128-32. doi: 10.1016/s0016-5107(91)70669-x.
Results Reference
background
PubMed Identifier
28652912
Citation
Tullavardhana T, Akranurakkul P, Ungkitphaiboon W, Songtish D. Efficacy of submucosal epinephrine injection for the prevention of postpolypectomy bleeding: A meta-analysis of randomized controlled studies. Ann Med Surg (Lond). 2017 Jun 6;19:65-73. doi: 10.1016/j.amsu.2017.05.035. eCollection 2017 Jul.
Results Reference
background
PubMed Identifier
30296436
Citation
Klein A, Tate DJ, Jayasekeran V, Hourigan L, Singh R, Brown G, Bahin FF, Burgess N, Williams SJ, Lee E, Sidhu M, Byth K, Bourke MJ. Thermal Ablation of Mucosal Defect Margins Reduces Adenoma Recurrence After Colonic Endoscopic Mucosal Resection. Gastroenterology. 2019 Feb;156(3):604-613.e3. doi: 10.1053/j.gastro.2018.10.003. Epub 2018 Oct 6.
Results Reference
background

Learn more about this trial

Efficacy of EndoClot™ Spraying After Endoscopic Resection of Large Colorectal Polyps

We'll reach out to this number within 24 hrs